Letko Brosseau & Associates Inc. reduced its stake in Profound Medical Corp. (NASDAQ:PROF – Free Report) by 0.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,164,125 shares of the company’s stock after selling 4,150 shares during the quarter. Letko Brosseau & Associates Inc. […]
Letko Brosseau & Associates Inc. increased its holdings in Rogers Communications Inc. (NYSE:RCI – Free Report) (TSE:RCI.B) by 1.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,948,946 shares of the Wireless communications provider’s stock after purchasing an additional 62,030 shares […]
Letko Brosseau & Associates Inc. lowered its holdings in shares of CEMEX, S.A.B. de C.V. (NYSE:CX – Free Report) by 13.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,763,196 shares of the construction company’s stock after selling 559,900 shares […]
Letko Brosseau & Associates Inc. decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 1.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 269,209 shares of the company’s stock after selling 3,090 shares during the quarter. Letko Brosseau & Associates Inc.’s holdings in Merck & Co., Inc. […]
Letko Brosseau & Associates Inc. trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 970,915 shares of the biopharmaceutical company’s stock after selling 1,925 shares during the period. […]